TARDBP and hepatocellular carcinoma: While HCC cases with high expression of EIF4A3, IGF2BP3, U2AF2, TARDBP, IGF2BP1, TAF15, HNRNPC, or PTBP1 had shorter OS in ICGC project (Figure 3A and Supplementary Figure 3).